Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about a scheduled one-on-one meeting with Renaissance Investment Managers on February 25, 2026. The disclosure is being made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, as a routine compliance update. The schedule is subject to change due to last-minute exigencies on either side. No financial, operational, or strategic information has been shared in this filing.
This is a routine investor engagement intimation and is unlikely to have any direct impact on the stock price. It simply signals that the company is continuing its normal investor relations activities with institutional investors.